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Summary 
The study of microorganism consortia, also known as biofilms, is associated to a number 
of applications in biotechnology, ecotechnology and clinical domains. Nowadays, biofilm 
studies are heterogeneous and data-intensive, encompassing different levels of analysis. 
Computational modelling of biofilm studies has become thus a requirement to make sense 
of these vast and ever-expanding biofilm data volumes. 
The rationale of the present work is a machine-readable format for representing biofilm 
studies and supporting biofilm data interchange and data integration. This format is 
supported by the Biofilm Science Ontology (BSO), the first ontology on biofilms 
information. The ontology is decomposed into a number of areas of interest, namely: the 
Experimental Procedure Ontology (EPO) which describes biofilm experimental 
procedures; the Colony Morphology Ontology (CMO) which characterises 
morphologically microorganism colonies; and other modules concerning biofilm 
phenotype, antimicrobial susceptibility and virulence traits. The overall objective behind 
BSO is to develop semantic resources to capture, represent and share data on biofilms and 
related experiments in a regularized fashion manner. Furthermore, the present work also 
introduces a framework in assistance of biofilm data interchange and analysis – 
BiofOmics (http://biofomics.org) – and a public repository on colony morphology 
signatures – MorphoCol (http://stardust.deb.uminho.pt/morphocol).  
1 Introduction  
Microorganisms have evolved various strategies to survive and adapt to the ever changing 
environmental conditions. The formation of biofilms is an example of such adaptation 
strategies. Biofilms are structured and complex sessile communities of microorganisms that 
are able to survive virtually everywhere in Nature because of their ability to adhere to a 
surface and embed in a protecting, self-produced matrix of extracellular polymeric substances 
[1-2].  
Due to their persistence and resistance to antimicrobial agents, biofilms cause a variety of 
problems in different areas of great importance to human development, such as the clinical, 
industrial and environmental settings. Biofilm-growing microorganisms affect, for instance, 
hygiene and food safety in the food industry [3], are responsible for nosocomial infections [4-
7], acute and chronic infections [8-10], and clogging and contaminations in drinking water 
systems [11-12]. In turn, biofilms play an important role in the ecological balance and can be 
“engineered” to carry out beneficial tasks in several biotechnological and bioengineering 
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processes, such as water and wastewater treatment, bioremediation and production of 
biocompounds in biofilm reactors [7,8]. 
Research in this field has a long trajectory, and similarly to other domains, biofilm research 
has benefited from the technological evolution occurred in the last decades [13-14]. The 
development of high-throughput biofilm-forming devices (e.g. the 96-well plate, the 
microtiter plate with coupons and the Calgary device) has enabled the simultaneous testing of 
large sets of conditions. In addition, biofilm studies involve technology and knowledge from 
multidisciplinary science fields. The implementation of automated spectrophotometry (e.g. 
microplate readers) and microscopy systems (e.g. scanning electron, atomic force, and 
confocal laser scanning microscopy) has empowered the large scale analysis of biofilm 
features, such as biofilm biomass, biofilm activity and microbial composition. The “omics” 
platforms also support the study of the transcriptome [15-16], proteome [17-19] and 
metabolome [20-21] of biofilms. 
Biologists are increasingly recognising that computational modelling is crucial for data 
interchange and for making sense of the vast quantities of complex experimental biofilm data 
that are now being collected. The current inability to exchange biofilm data has its roots in the 
limited access to existing data and the lack of a common format for describing biofilm 
experiments and the results obtained [22]. This work is the first that addresses the 
standardisation of biofilm studies and proposes a machine-readable format for their 
representation.  
After this introduction, the paper is organised as follows. Section 2 identifies the main 
challenges to be faced in biofilm data modelling. Section 3 presents the controlled vocabulary 
and the machine-readable format that have been created to meet modelling and processing 
requirements. Section 4 introduces the computational resources that have been developed to 
support biofilm data interchange and data integration. Section 5 resumes the rationale of the 
initiative and delineates future lines of work. Some conclusions and acknowledgments to 
researchers supporting the initiative can be found at the end of the paper.Heading for a 
subsection 
2 Biofilm Data Modelling/Management 
Even for a well-defined research domain, an universal language that fits all purposes and 
interests is very hard to be achieved. Nowadays, biofilm studies often encompass 
multidisciplinary approaches from biology, chemistry, medicine, material science and 
engineering, among others. Furthermore, biofilm experiments vary greatly in terms of tested 
conditions and methods of analysis used. Nevertheless, it is reasonable to assume that studies 
on similar subjects (e.g. stress response, antimicrobial susceptibility testing) should share 
elements of information - a set of minimum information. Consequently, a common 
intermediate format could be established to enable communication of the most essential 
aspects of the biofilm related studies. 
2.1 Access to Biofilm Data 
Most biomedical databases are populated by curating scientific literature and deriving data 
from secondary sources (e.g. sequence databases). Biofilms domain is different though, as 
biofilm publications only summarise the obtained results (mostly general statistics, such as 
mean and standard deviation values). Raw data is not provided in supplementary material or 
submitted to any public location. The source of biofilm data is the private archives of 
researchers. Furthermore, biofilm data files do not comply with a standard format. Data files 
vary widely from laboratory to laboratory, from researcher to researcher and even from a 


























































































































researcher’s experiment to the next (Figure 1). Data files are organised on an ad hoc, as-
needed basis and lack comprehensive documentation on the experimental conditions 
evaluated in each biofilm study (often they are only mentioned by abbreviations or non-
documented mnemonics) and, more important, on data quantification (e.g. a simple matter 
such as the units of measure used). Data curation is thus very hard to achieve without the help 
of researchers, even for experienced curators. 
 
 
Fig. 1: Examples of original data files from already published studies. 
So, for now, data access is dependent on the willingness of researchers to participate in 
interchange initiatives. It is necessary to raise awareness of the importance (and benefits) that 
data interchange can represent to individual studies while promoting collaborative studies and 
the harmonization of procedures across laboratories. Indeed, the authors of the present work 
truly believe that data interchange should be proposed as a community initiative and the 
discussion of such initiative should involve as many researchers as possible. Dissemination 
activities, for example in biofilm-related conferences, and discussion forums, are considered 
important purposes to bring forward researchers’ participation. 
2.2 Characterization of Biofilm Studies 
As referred, biofilm studies vary greatly in terms of experimental methodology and analysis 
purposes. Nowadays, most studies take advantage of high-throughput technologies to test a 
large number of conditions simultaneously and acquire different data about biofilm 
“behaviour”.  
Many in vitro systems have been developed for developing and testing microbial biofilms. 
These systems include simple batch/static systems, batch systems with induced shear, flow 
cells and systems operated under continuous-flow conditions (e.g. rotating-disk reactor) that 


























































































































generally provide a surface that can be removed and examined once it is colonised to assess 
biofilm formation. In recent years, microtiter-plate methods began to be used to grow and 
assess biofilms in large-scale [10,11]. Crystal violet staining and direct quantification by 
optical density were initially part of these new systems but, due to its larger data generation 
ability, the application of colorimetric assays has expanded in the meantime. Assays are now 
able to assess not only biofilm formation as a whole but also to quantify microbial numbers 
using, for instance, the Syto 9 assay; microbial physiological activity by the fluorescein 
diacetate assay; or even the extracellular biofilm matrix using the dimethyl methylene blue 
assay [12]. For all microtiter plate-based assays, the final results are based either on colour or 
fluorescence intensity at a certain wavelength, which means that rapid, quantitative analyses 
are obtained from a single equipment such as an automated multiscan reader. 
To define a common intermediate format to exchange such heterogeneous biofilm data and 
account for multiple analysis goals (and implicitly, results interpretation), it is needed to 
define a set of minimum information – a signature – that reflects the most essential aspects of 
the biofilm studies. It is important to emphasise that results are fully comparable only for 
similar methods under identical conditions. Moreover, it is necessary to compile terminology 
about these elements of information such that descriptions are unambiguous and well-
documented. 
A biofilm signature should include information about the experiments but also “credits” 
information. The signature should identify the team that developed the study, a summary of 
its main findings (produced by the authors) and eventually other notes of interest, and the 
reference to any peer-reviewed publications that credit the quality and importance of the 
study. This information is important at different levels: it credits the authorship of the data 
made public, authors/submitters are accounted responsible for the quality of the overall 
signature, and researchers are provided first-hand notes (and other useful insights) of the 
experiments. 
The information about the biofilm experiments depends heavily on the purpose of the study. 
Due to research interests of the authors of this work and their expertise in the field, this 
present work has focused on the documentation of studies about antimicrobial susceptibility, 
biofilm adhesion to abiotic surfaces and biofilm stress response. The set of minimum 
information that was considered essential to the documentation of these studies was as 
follows: 
• the microorganisms composing the biofilm consortia and their sources (e.g. mutants, 
clinical isolates, reference strains); 
• the experimental setup, including biofilm-forming devices, growth media and 
adhesion materials; 
• the antimicrobial products tested, specifying the concentration and time of application;  
• the analytical methods used, including data processing (e.g. the calculation of dilution 
rates or log reductions) and statistical validation (e.g. number of replicates and 
reproductions, negative and positive controls, etc.). 
2.3 A Machine-readable Format for Biofilm Data 
Standardizing biofilm data on a common format is essential for being able to move forward 
with large-scale collaborative analysis. It removes any impediment to sharing results and 
permits other researchers to reproduce the experiment, examine it carefully, propose 
extensions, and apply new techniques and analysis.  
The definition of a common format to standardise biofilm data should take into account the 
costs associated to the curation of existing data. It is important to relieve researchers from the 


























































































































need to acquire computational skills and/or adapt to new tools, and focus their attention on the 
curation of the large volume of existing data. Because many of the researchers working in the 
biofilm area use the familiar Microsoft Excel worksheets to store data from biofilm 
experiments, it has been decided to adopt this format as a first mean to implement the biofilm 
data interchange format. Experimental conditions are distributed into worksheets (Figure 2). 
Single value conditions (i.e. the conditions that remain constant in the experiment) are at one 
worksheet. Then, for each method of analysis used, one worksheet is created. In these 
worksheets, multi-value conditions (i.e. the conditions that have several tests) are organised 
hierarchically in descendent order. This hierarchical structure is allowed to grow vertically – 
as many sub-levels as condition tests and experiment reproductions there are – and no 
restriction is imposed to the length of the data series of each-level (i.e. the number of 
replicates for each condition test). 
 
Input: Econd: list of experimental conditions; Ma: list of 
methods of analysis 
Output: Fexcel customised file 
 
𝐸𝑐𝑜𝑛𝑑_𝑠𝑖𝑛𝑔𝑙𝑒 ← 𝑠𝑖𝑛𝑔𝑙𝑒𝑉𝑎𝑙𝑢𝑒𝐶𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛𝑠(𝐸𝑐𝑜𝑛𝑑) 
𝐸𝑐𝑜𝑛𝑑_𝑚𝑢𝑙𝑡𝑖 ← 𝐸𝑐𝑜𝑛𝑑 − 𝐸𝑐𝑜𝑛𝑑_𝑠𝑖𝑛𝑔𝑙𝑒 
𝑤𝑠 ← 𝑖𝑛𝑖𝑡𝑖𝑎𝑙𝑖𝑠𝑒𝑊𝑜𝑟𝑘𝑠ℎ𝑒𝑒𝑡(′𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡𝑠′) for 𝑐 ∈ 𝑠𝑜𝑟𝑡𝐵𝑦𝑇𝑦𝑝𝑒(𝐸𝑐𝑜𝑛𝑑𝑠𝑖𝑛𝑔𝑙𝑒) 
     𝑤𝑠 ← 𝑓𝑖𝑙𝑙𝐼𝑛(𝑐.𝑛𝑎𝑚𝑒, 𝑐. 𝑣𝑎𝑙𝑢𝑒) end Fexcel ← addWorksheet(ws) 
 
for 𝑚 ∈ 𝑀𝑎        𝑤𝑚 ← 𝑖𝑛𝑖𝑡𝑖𝑎𝑙𝑖𝑠𝑒𝑊𝑜𝑟𝑘𝑠ℎ𝑒𝑒𝑡(𝑚.𝑛𝑎𝑚𝑒) for 𝑐 ∈ 𝑠𝑜𝑟𝑡𝐷𝑒𝑠𝑐𝑒𝑛𝑑𝑁𝑢𝑚𝑉𝑎𝑙𝑢𝑒𝑠(𝐸𝑐𝑜𝑛𝑑𝑚𝑢𝑙𝑡𝑖)            𝑤𝑚 ← 𝑓𝑖𝑙𝑙𝐼𝑛𝐻𝑖𝑒𝑟𝑎𝑟𝑐ℎ𝑦(𝑐.𝑛𝑎𝑚𝑒, 𝑐. 𝑣𝑎𝑙𝑢𝑒𝑠) end       Fexcel ← addWorksheet(wm) end 
 
return Fexcel 
Fig. 2: Pseudo-code of the systematic construction of biofilm structured data files. 
3 Computational Resources in Support of Biofilm Studies 
3.1 Controlled vocabularies and metadata annotations 
To effectively search and analyse biofilm data, data should be well organized and 
semantically integrated. An important tool for searching, integrating and analysing data from 
databases is record metadata annotation, supported by controlled vocabulary. Hence, it was 
developed the first ontology on biofilms and their study – the Biofilm Science Ontology 
(BSO). BSO is a neutral species ontology, developed following the basic principles of the 
OBO Foundry [23]. BSO is designed to develop shared, structured and accurated vocabularies 
for the annotation of the general biofilm experimental workflow. BSO is intended for the 
broad research community, including bench microbiologists, clinical researchers, clinicians, 
curators and bioinformaticians. Structure and definitions are freely accessible at OBO foundry 
Web site (http://miabie.org/ontology). Definitions of BSO terms are provided from actual 
knowledge and consensual statements about biofilms obtained from reference works and 
discussed with well-known experts in the field. 
BSO is modular, i.e., is composed by specialized ontologies covering all areas of biofilm 
studies. The Experimental Procedure Ontology (EPO) and the Colony Morphology Ontology 
(CMO) were two of the first modules that are being fully developed. EPO can be used to 


























































































































annotate descriptions for biofilm experiments workflow, namely biofilm formation and all 
operating procedures involved (Figure 3). 
CMO is one of the well-established modules of BSO due to the emergent significance of 
colony morphology observations in the understanding of antibiotic resistance, persistence and 
virulence [24]. Colony morphologies have been intensively studied due to its medical 
importance, without internationally accepted guidelines for colony description, classification 
or even designation. Besides, the main source of information about colony morphology 
variation is the peer-reviewed journal literature. Therefore, CMO was developed to 
consistently describe morphological traits of colony bacteria (Figure 4), as well as to enable 
data accessibility, use and understanding. CMO attempts to capture the precise meaning of 
colony morphology terms avoiding variability, heterogeneity and ambiguity. The retrieval, 
integration and analysis of colony morphology data will become undoubtedly easier using 
universal and unquivocal ontologies that have to be independent of colony morphotypes, 
laboratories, researchers or even the experimental protocols used. 
 
 
Fig. 3: General tree view of EPO within BSO structure. 
 
Other modules of BSO are currently under development, namely the ontology of biofilm 
signature, antimicrobial resistance and virulence traits of biofilm cells. Such ontologies 
represent the knowledge underlying description of biofilm composition and architecture, 
biofilm-cell phenotype and biofilm matrix.  
Through BSO using, biofilm data become interoperable and consistent because of its 
unambiguously description, search, integration and analysis. In addition, standardization can 
readily transform the biofilm research and applications and promote the integration of 
biofilms in other science areas. 



























































































































Fig. 4: General tree view of CMO insert in BSO structure. 
3.2 BiofOmics Framework: Means to Compare and Interchange Data 
BiofOmics is a novel Web framework that aims to make readily available biofilm studies and 
enable comparative and collaborative studies. It is meant to provide accommodation to 
existing data, but far more important, ensure data standardization.  
The existence of a database compiling existing biofilm data in a computer-amenable way 
simplifies research in a number of ways: the search for similar experiments (Figure 5), the 
interchange of data between researchers and laboratories, the search for “open spots” (i.e. 
relevant but under-reported areas), and the comparative analysis of experiments (in particular, 
inter-laboratory collaborations). Besides the obvious value of widespread dissemination of 
biofilm research, researchers are also rewarded with the possibility to ameliorate the 
supplementary materials accompanying publications; a (major) step forward to endorse the 
transparency and high-quality of biofilm experimental data as well as the validity of the 
results and discussion being published. 
The BiofOmics platform is already operative. Its facilities were validated through the 
introduction of existing experiments, representative of key research topics (and purposes of 
analysis) and involving latest high-throughput technologies and methodologies. As an 
example, experiments dealing with the resistance of biofilms to antimicrobial agents typically 
have data from biofilms before, during and after exposure to the agents. In this scenario, 
researchers will be most likely interested in comparing the values collected and for this 
purpose, values have to be adequately characterized in the database. Owing to the amount of 
information involved in high-throughput biofilm experiments, the number of data points 
involved in the tests exceeded 10000.  



























































































































Fig. 5: BiofOmics facility for public biofilm data search. 
3.3 MorphoColDB: a Database on Colony Morphotypes 
MorphoColDB aims to be a comprehensible knowledge base on colony morphologies, i.e., the 
morphological characterisation of microorganism consortia under various environmental 
conditions and stages of their formation and development. Some morphological features of 
colonies are linked to important biological processes, such as antibiotic resistance [24] and 
microbial virulence. For instance, small colony variants of some bacteria are strongly 
associated to resistance to a broad range of antibiotics of clinical use. Due to its clinical 
importance, colony morphology studies are thus ever growing and MorphoCol was developed 
as an instrument to help the management and manipulation of this fast proliferation of 
information about colony morphology (Figure 6).  
The main source of information about colony morphology variation is the scientific literature. 
Normally, manuscripts describe the setup of the experiments, as well as the colony 
morphologies observed. They also provide images about the colony morphologies, which are 
of obvious interests for observation and comparative purposes, but it is anticipated that most 
are bound to journal copyright constraints. Therefore, although the data curation workflow 
established in MorphoColDB is based in the curation of scientific literature (reached out 
mainly through PubMed), contact with authors is necessary as an additional source of data.  
Another important step of this data curation workflow is the systematic and standardised 
labelling of the colony morphologies. Researchers use various terminologies, often even 
create new terms, to describe the morphological features observed in their experiments. 
MorphoColDB annotation process is supported by the CMO, which has gathered and 
processed these heterogeneous terminologies. Curators are responsible for the annotation of 
the submitted images. Furthermore, MorphoColDB enables the integration of multiple layers 
of information, namely colony morphology annotations (based on CMO) and data from 
transcriptomic, proteomic, and metabolomic analyses.  


























































































































MorphoColDB offers a way to rationally inquire about bacteria more resistant or/and more 
virulent and may has a significant impact on medical decision support, namely in design of 
antibiotic therapy. To begin with, the knowledge base is gathering information on 
Pseudomonas aeruginosa and Staphylococcus aureus strains, two pathogenic bacteria 
commonly associated with biofilm-related nosocomial infections. 
 
 
Fig. 6: MorphoCol site on colony morphology. 
4 Rationale and On-going Work 
In this work, some computational contributions to standardise biofilm data and enable data 
integration and large-scale decision making are presented.  
The common intermediate format introduced with the present work is neutral with respect to 
programming languages and software encoding. By supporting this format for reading and 
writing biofilm signatures, different software tools (including programs for building and 
editing data files, analysis and simulation programs, databases, and other systems) can 
directly communicate and store the same computable representation of those files. This 
removes any barrier to sharing results and permits other researchers to start with an 
unambiguous representation of the data, examine it carefully, and apply new techniques and 
approaches (i.e. collaborative and “incremental” studies). 
The frameworks, BiofOmics and MorphoColDB, are the first to deliver readily access to 
biofilm studies and encompass such a wide scope of areas of interest and various layers of 
information. They facilitate the gathering and annotation of the large volumes of biofilm data 
available. They also simplify and make more explicit the association between biofilm 
experiments and scientific statements, i.e., the connection between data and work findings, 
presenting them in a condensed and accessible form. Laboratories can rationalise their work 
and avoid losing information and know-how by storing data and protocols in homogeneous 
formats, objectively annotated and understandable; accessible results and experimental, 


























































































































analysis and statistical protocols can avoid duplication of efforts; accessible results can also 
control the loss of competences by operator turnover. 
The computational efforts developed in the scope of the present work are sustained by BSO-
derived ontologies which facilitate the communication between researchers and scientific 
groups, unequivocally describing biofilm signatures. Indeed, the agreement about sharing 
semantic definitions is crucial to advance biofilm understanding.  
After a number of international conferences, informal meetings, courses and workshops, the 
computational initiatives introduced by the present work have managed to catalyse a 
community of interested researchers, developers, and users who are now collaborating on 
evolving the above mentioned tools and creating new resources around them. This is a clear 
reflection of an urgent need in the community to address issues of harmonisation and 
interoperability. At the same time, it is believed that the challenges faced by these projects 
and the solutions that are arising have underlying components that would be faced by any 
effort to define a similar standard exchange format.  
Indeed, the team is working on the definition of the Minimal Information About Biofilms 
Experiments – MIABiE (http://miabie.org) – which aims to provide guidelines to the adequate 
documentation of biofilm-related studies. MIABiE arose from the need to find an adequate 
and scientifically sound way to control and store the data from biofilm experiments, 
particularly those involving high-throughput devices. MIABiE is a member of MIBBI 
(http://mibbi.sourceforge.net/), an initiative that provides a common portal to minimum 
information checklists from all areas of biological and biomedical sciences. 
5 Conclusions 
Nowadays, biofilm studies are heterogeneous and data-intensive, encompassing different 
levels of analysis. The understanding of microorganism consortia would benefit greatly from 
the ability to integrate data from similar studies and confront distinct levels of analysis. 
Computational approaches to interchange studies and scale up biofilm analysis are desired. 
Besides limited access, no protocol exists on how to document biofilm studies, i.e., the 
minimum information required to guarantee self-contained and explanatory documentation. It 
does not take prescience to see that infrastructure such as SBML, databases, and more 
powerful analysis tools are needed to support continued progress in biofilm science. 
The high-throughput technologies accelerated the rate of generating data on biofilm domains. 
As aforementioned, biofilm research relies increasingly on large collections of data sets. This 
“big data” dimension calls for the development of novel computational tools, specialised in 
biofilm data management, interchange and analysis. However, the authors of the present work 
are unaware of any efforts to standardise and disseminate biofilm data at large scale. 
Currently, sharing of biofilm data among researchers is poor at best, in detriment of research 
and community at large.  
Access to primary high-throughput biofilm data alone is useless unless those data would be in 
form of accurate analysis and interpretation. Thus, data standardisation is crucial to make 
knowledge more explicit, help detect errors, ensure data reliability, and promote data 
interchange. Standardization augments the global value of results and leading to great advance 
of science knowledge. This advance is not limited to scientific purposes, as industrial interests 
might gain serious advantages.  
The informatics approaches presented here to the standardised organisation of biofilm data 
demonstrated to be critically important for data sharing, unambiguous representation, 
validation and interpretation of data, semantic search and query, and data integration. In 


























































































































addition, they ensure data quality, reliability and reproducibility. All approaches have been 
validated with a number of highly variable, already published experiments and it is already in 
practice, supporting the operation of the BiofOmics and MorphoCol databases. These 
databases facilitates data search and comparison as well as data interchange between 
laboratories (publicly accessible at http://biofomics.org and http://morphocol.org
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